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Abstract 
Purpose:  The aim of this study is to investigate the relationship between arterial pulse amplitude change under 
increased shear stress and the presence of ischemic heart disease (IHD).
Methods:  This study comprised 31 subjects, including 14 subjects with IHD. We investigated the change in brachial 
artery pulse amplitude during flow-mediated dilation (FMD) using ultrasonography.
Results: The arterial pulse amplitude increased during FMD in 19 subjects, whereas it decreased in 12 subjects. There 
was a marked difference in the change in arterial pulse amplitude (the maximum amplitude of the arterial pulse 
amplitude during FMD/the arterial pulse amplitude at baseline) between subjects with and without IHD (0.98 ± 0.53 
and 1.37 ± 0.53, p = 0.028). Furthermore, decreased arterial pulse amplitude during FMD was a significant predictor 
of IHD after adjustment of age, blood pressure, the presence of each type of coronary risks, the value of FMD and sex 
(p = 0.0001).
Conclusions: The decrease of arterial pulsation amplitude during FMD was a useful predictive parameter for IHD.
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Background
Shear stress is one of the potent factors related with the 
progression of atherosclerosis (Samady et al. 2011). Low 
shear stress leads to a proatherogenic vascular condi-
tion, which subsequently leads to the focal develop-
ment of atherosclerosis in early lesions (Koskinas et  al. 
2009). In contrast, high shear stress has been shown to 
enhance plaque vulnerability in the later stage of athero-
sclerosis (Kenagy et al. 2002). If there is a stenotic lesion 
in a coronary artery that increases the shear stress at the 
stenotic site (Thim et al. 2012; Vita et al. 1989), the vas-
culature responds to this flow-limiting condition and 
compensates for it by arterial remodeling, resulting in a 
decrease in shear stress (Vita et al. 1989; Silver and Vita 
2006). On the other hand, this compensation response is 
lost in dysfunctional vasculature, resulting in failure to 
control shear stress and the progression of atherosclero-
sis. Therefore, the ability to compensate for altered shear 
stress is considered to correspond to the risk of athero-
sclerosis progression.
Multiple aspects of vascular function have been 
reported to relate to atherosclerotic processes (Bonetti 
et al. 2003). Among them, flow-mediated dilation (FMD) 
is one of the methods used to evaluate the state of 
endothelial cell function (Watanabe et al. 2013). During 
FMD measurements, increased blood flow after vascular 
occlusion is required to stimulate endothelial cells. This 
situation shares similarity with atherosclerotic vessel ste-
nosis, with respect to the increase in shear stress. Thus, 
vascular behavior during FMD is presumed to correlate 
with the compensative vascular response to the presence 
of high shear stress lesions. Therefore, the documenta-
tion of vascular behavior in the presence of increased 
flow and shear stress during FMD is considered to be 
useful information to predict the process of atheroscle-
rosis. FMD is a baseline diameter behavior under high 
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shear stress; however, it only reflects one specific hemo-
dynamic movement in a limited manner, and vascular 
functions observed by other modalities may complement 
its predictive power for atherosclerotic diseases (Watan-
abe et al. 2014).
Arterial pulsation is produced by an increase in blood 
pressure during systole. The amplitude of the pulsa-
tile dilation is determined by the arterial wall stiffness, 
its vascular tone, and pulse pressure (Budoff et al. 2003; 
Giannattasio and Mancia 2002). Arterial pulsation behav-
ior can be observed using echographic serial monitoring 
or magnetic resonance modalities (Voges et  al. 2012); 
however, its characteristics have not been well elucidated.
Recently, it has been shown that arterial stiffness, 
which is measured by pulse wave velocity (PWV), can 
change during the FMD process (Naka et al. 2006). Flow-
mediated changes in the PWV have been reported to be 
impaired in subjects with endothelial dysfunction, when 
compared with normal controls. In this manner, impair-
ment of the ability to change vascular behavior during 
FMD seems to correspond to the presence of cardiovas-
cular disease. However, the relationship between vascu-
lar disease and the behavior of arterial pulsation during 
FMD has not been well documented. The objective of 
this study was to compare the behavior of arterial pulsa-
tion in subjects with and without ischemic heart disease 
(IHD) and clarify the association of vascular behaviors 




This study enrolled 31 subjects who were hospitalized 
in the Cardiovascular Department at the University of 
Tokyo Hospital. The study subjects were recruited from 
the consecutive patients of hospitalization for the diag-
nostic cardiac catheterization for IHD and diagnos-
tic electrophysiological study for arrhythmia, whose 
informed consent was obtained. The subjects whose 
results of arterial pulse tracing were poor image and 
cannot be analyzed were excluded (we excluded 12 sub-
jects). As a result, the study subjects included 17 subjects 
without IHD and 14 subjects with IHD. IHD was defined 
as the presence of at least one of the following: >50  % 
luminal diameter narrowing of more than one epicardial 
coronary artery on angiography, a history of coronary 
revascularization, or a history of myocardial infarction. 
The exclusion criterion was the presence of unstable 
clinical conditions. All components of standard informed 
consent, including the purpose of the study, the risk, and 
the benefits, were fully explained. Written informed con-
sent was obtained from each subject. The study protocol 
conformed to the tenets of the Declaration of Helsinki 
and was reviewed and approved by the University of 
Tokyo Institutional Review Board (3003).
FMD measurement
FMD was measured in accordance with the method 
established in a publication by the International Brachial 
Artery Reactivity Task Force (Corretti et  al. 2002). The 
subjects were instructed to abstain from eating, smoking, 
and caffeine consumption for at least 4 h prior to the start 
of the study and to lie down for 20 min. FMD of the bra-
chial artery was measured using amplitude- and bright-
ness-mode ultrasonography with a linear array 10-MHz 
transducer (UNEXEF18G; UNEX, Nagoya, Japan). After 
collecting baseline diameter measurements for 30 s, the 
cuff was inflated to 50 mmHg above the patient’s systolic 
blood pressure, maintained at this pressure for 5 min, and 
then deflated (Watanabe et al. 2013). The diameter of the 
brachial artery was continuously recorded for 2 min after 
the cuff was deflated. The diameter was always measured 
during the end-diastolic phase, defined as the beginning 
of the R wave in the electrocardiogram. FMD was calcu-
lated as the percentage change in artery diameter from 
the baseline value before cuff release to the peak value 
after cuff release.
Arterial pulse amplitude
We investigated the change in brachial artery pulsation 
during hyperemia-induced vasodilation using ampli-
tude- and brightness-mode ultrasonography with a lin-
ear array 10-MHz transducer (UNEXEF18G; UNEX, 
Nagoya, Japan). Each arterial pulsation waveform was 
measured and standardized to the value of the end-
diastolic diameter of each pulsation. Figure 1a shows an 
example waveform from one of the subjects. The arterial 
pulse amplitude (%) was defined as: 100 ×  ([the maxi-
mum diameter of the brachial artery during one car-
diac cycle]/[the end-diastolic diameter during the same 
cardiac cycle]  −  1) (Fig.  1b). The intraclass correlation 
coefficient of the arterial pulse amplitude was 0.882 
(N =  16). The waveforms at rest and at the 20th, 40th, 
60th, 80th, 100th, and 120th heart pulses were compared 
after deflation of the cuff during FMD measurement 
(Fig.  1c). Two examples of this waveform series during 
FMD are presented in Fig. 1c. These examples show that 
the arterial pulse amplitude was enhanced during hyper-
emia-induced shear stress stimulation in the dilating 
phase of the end-diastolic diameter in Patient 1, whereas 
the arterial pulse amplitude decreased in Patient 2. The 
peak amplitude of arterial pulsation was traced during 
the process of FMD (Fig. 1d). The end-diastolic diameter 
gradually dilated during FMD, but the range of dilation 
was too small; thus, it did not explain the enhancement 
in arterial pulsation. The arterial diameter was recorded 
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every 13 ms and it was traced 650 ms after the Q wave in 
each pulse.
Statistics
Data are presented as the mean  ±  standard deviation. 
Differences between groups were evaluated using the 
Mann–Whitney U test, t test, and χ2 test. Potential rela-
tionships between parameters were explored using Pear-
son’s correlation test. A logistic regression analysis was 
performed to determine whether or not the decrease in 
arterial pulse amplitude during FMD remained a predic-
tor of IHD even after adjustment for age, FMD, the value 
of arterial pulsation, coronary risk factors, and sex. The 
results of comparison are represented as box plots (mid-
dle hash of the box indicating the median; 25th–75th 
percentiles represented by end caps of the box; whiskers 
extend to the last observed value). A p value <0.05 was 
considered to be statistically significant. Data analyses 
were performed using the PASW Statistics 18 (SPSS Inc., 
Chicago, IL, USA) and JMP Pro 9 (SAS Institute, Cary, 
NC, USA) software packages.
Results
The background characteristics of the subjects with and 
without IHD are presented in Table  1. There were no 
significant differences in blood pressure, heart rate, or 
several clinical parameters among the subjects with and 
without IHD, whereas the ratio of hypertension and the 
prescription of calcium blockers (41 vs 90  %) and beta 
blockers (29 vs 78  %) were significantly higher in sub-
jects with IHD. In terms of vascular function param-
eters, the values of FMD and arterial pulse amplitude 
were not significantly different between subjects with 
and without IHD. Indeed, none of the coronary risk fac-
tors (diabetes, hypertension, advanced age, or hyperlipi-
demia), medications (beta blockers or calcium blockers), 
or other clinical parameters had any association with the 
value of arterial pulse amplitude (not shown). Age is an 
Fig. 1 a Continuous monitoring of the arterial pulsation waveform during flow-mediated dilation (FMD). The arterial diameter was monitored using 
amplitude- and brightness-mode ultrasonography with a linear array 10-MHz transducer (UNEXEF18G, UNEX, Nagoya, Japan). b Definition of the 
arterial pulse amplitude. The change in arterial diameter over the course of one cardiac cycle is presented. c Two characteristic examples of arterial 
pulsation behavior during FMD. The arterial pulse amplitude increased during FMD in Patient 1, whereas it decreased in Patient 2. d The arterial 
pulse amplitude is plotted along the time course of FMD for Patients 1 and 2
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only parameter which associated with arterial pulsation 
amplitude (R = 0.38, p = 0.036)
Next we investigated the change in arterial pulse ampli-
tude during FMD (Fig. 1c, d). The change in this ampli-
tude usually increased during the first time course of 
FMD and returned to baseline about 90  s later (as for 
Patient 1 in Fig.  1c). We defined the change in arterial 
pulse amplitude as the maximum change of the arterial 
pulse amplitude during FMD divided by the arterial pulse 
amplitude at baseline. The arterial pulse amplitude dur-
ing FMD increased in 19 subjects and decreased in 12 
subjects. The change in the arterial pulse amplitude was 
strongly associated with the arterial pulse amplitude at 
baseline (R = −0.73, p  <  0.0001), brachial artery diam-
eter (R =  0.37, p =  0.038) and body mass index (BMI) 
(R = 0.55, p = 0.015) (Fig. 2a). However, the other clini-
cal parameters, including FMD (Fig.  2b), were not sig-
nificantly correlated with the change in arterial pulse 
amplitude. In addition, the presence of coronary risk fac-
tors and the prescription of calcium blockers (1.26 ± 0.63 
(off) vs 1.18  ±  0.55 (on), p  =  0.66) or beta blockers 
(1.35 ± 0.49 (off) vs 1.08 ± 0.62 (on), p = 0.15) did not 
affect the change in arterial pulsation amplitude.
We compared the change in arterial pulse amplitude 
and FMD between subjects with and without each of 
the coronary risk factors (diabetes, hypertension, hyper-
lipidemia) or high age (more than 65 years old) or IHD. 
There were significant differences in FMD with and 
without each of the coronary risk factors and the pres-
ence of high age, whereas there were no differences in 
the change in the arterial pulse amplitude (Fig.  3). By 
contrast, there was a marked difference in the change 
in arterial pulse amplitude between subjects with and 
without IHD (0.98 ± 0.53 and 1.37 ± 0.53, respectively; 
p  =  0.028), whereas the value of FMD was not signifi-
cantly different. In addition, the prevalence of IHD was 
significantly higher in the subjects with decreased arterial 
pulse amplitude during FMD than it was in those with 
increased arterial pulse amplitude (75 vs. 26.3  %). After 
adjusting for age, FMD, the value of arterial pulsation, 
Table 1 Patient characteristics in  subjects with  and with-
out IHD
IHD ischemic heart disease, FMD flow-mediated dilation, BP blood pressure, NS 
not significant
IHD (−) IHD (+)
N (male/female) 17 (5/12) 14 (13/1)
Age (years) 62.1 ± 15.1 69.5 ± 7.8 NS
Systolic BP (mmHg) 129.3 ± 25.4 130.0 ± 16.2 NS
Diastolic BP (mmHg) 67.4 ± 12.7  72.8 ± 11.6 NS
Pulse pressure (mmHg) 62.2 ± 22.2 57.2 ± 12.0 NS
Heart rate (/min) 69.3 ± 14.6 63.9 ± 11.1 NS
Diabetes 3 (17 %) 5 (35 %) NS
Hypertension 6 (35.3 %) 14 (100 %) p = 0.0005
Dyslipidemia 9 (52 %) 11 (78 %) NS
Beta-blocker 5 (29 %) 11 (78 %) p = 0.0052
Calcium blocker 7 (41 %) 13 (93 %) p = 0.0015
Arterial pulse amplitude 2.9 ± 1.4 3.5 ± 1.8 NS
FMD (%) 6.2 ± 3.7 4.2 ± 2.5 NS
Brachial artery diameter (mm) 3.9 ± 0.7 4.1 ± 0.6 NS
Fig. 2 Scatter plot of the change in arterial pulse amplitude and body mass index (BMI) (a) and flow-mediated dilation (FMD) (b)
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coronary risk factors, and sex, the decrease in arterial 
pulse amplitude during FMD had significant predictive 
power for the presence of IHD (p = 0.0001).
Discussion
In the present study, we observed an enhanced arte-
rial pulse amplitude during FMD that was reduced in 
the presence of IHD. The enhancement of the arterial 
pulse amplitude was not considered to be due to the 
change in blood pressure (Naka et  al. 2003), which has 
been reported to be a factor regulating arterial pulsation 
(Giannattasio and Mancia 2002), because the blood pres-
sure was somewhat stable during FMD (Naka et al. 2006). 
The finding that the arterial pulse amplitude returned 
to the baseline level suggests that the arterial pulsation 
enhancement during FMD is only a temporary response 
induced by increased shear stress after cuff release. 
Karner et al. (1999) demonstrated a reduced shear stress 
in a distensible vessel model as compared with that in the 
rigid model. The enhancement of arterial pulse amplitude 
is presumed to reduce the load of shear stress, and it is 
therefore considered to be an adaptive response, whereas 
the opposite response, such as decreasing arterial pulse 
amplitude, corresponds to a maladaptive response.
Previously, Kamran et al. (2010) demonstrated that the 
PWV, a useful marker of arterial stiffness, changes during 
FMD, and that this change is correlated with the value 
of the FMD. These results suggest that some endothe-
lial-derived factor produced during FMD, such as nitric 
oxide, affects vascular stiffness, resulting in a change 
in the behavior of the PWV. In a similar manner, the 
enhancement of the arterial pulse amplitude observed in 
the current study was supposed to be derived from the 
effect induced by increased shear stress during FMD. 
However, we could not detect any correlation between 
FMD and the change in arterial pulse amplitude, suggest-
ing that the main contributor to the enhanced arterial 
pulse amplitude is not nitric oxide derived from stimu-
lated endothelial cells and, therefore, there is another 
determining factor. Surprisingly, several cases in the pre-
sent study demonstrated a decrease in arterial pulsation 
instead of an increase. This suggests that there may be a 
factor other than a dilating factor like nitric oxide that 
has significant potency to suppress arterial pulsation in 
the dysfunctional vessels. Indeed, shear stress increases 
stimulate the endothelial release of several vasoactive 
substances, such as prostaglandins, endothelial-derived 
hyperpolarizing factor, endothelin, and acetylcholine 
(Koller et  al. 1993; Kuchan and Frangos 1993; Martin 
et al. 1996) and these factors had been reported to affect 
arterial stiffness (McEniery et  al. 2003). On the other 
hand, Ramsey et al. (1995) observed the increase in bra-
chial artery distensibility during FMD in similar manner 
and, it was lost in subjects with heart failure. The authors 
concluded that the absence of arterial pulsation enhance-
ment during FMD in subjects with heart failure was 
derived from the impairment of blood flow. However, the 
decrease of arterial pulse amplitude observed in the cur-
rent study cannot be explained by that mechanism.
Interestingly, there were marked differences in FMD 
between subjects with and without each coronary fac-
tor and high age, whereas there were no differences in 
the change in arterial pulse amplitude. These observa-
tions suggest that the change in arterial pulse amplitude 
is independent of these risk factors, by which the value 
of FMD is significantly affected. Therefore, the change 
in arterial pulse amplitude will present a different sus-
ceptibility to the progression of atherosclerosis that is 
independent of coronary risk factors. Thus, the change in 
arterial pulse amplitude may represent a novel coronary 
risk marker.
To investigate the determinant factor for the change in 
arterial pulse amplitude, we demonstrated the clear cor-
relation between BMI and the change in arterial pulsa-
tion amplitude. It is somewhat paradoxical because many 
previous reports demonstrated the attenuation of vascu-
lar function in the presence of obesity (Bagi et al. 2012). 
However Higashi et  al. (2003) reported similar results 
that lower BMI attenuated the response of endothelium-
derived vasodilation and it was derived from the increase 
of oxidative stress in subjects with low BMI. Therefore, 
there may be some associations between obesity related 
factor and the response of arterial pulsation amplitude 
during FMD, however it warrants further investigations.
Alterations in wall shear stress have been implicated in 
the focal distribution of coronary artery disease (Dhawan 
et al. 2010). Atherosclerotic plaques predominantly form 
in regions of low shear stress, whereas regions of physi-
ological moderate shear stress are generally protected in 
the early stage of atherosclerosis (Wentzel et  al. 2012). 
On the other hand, advanced plaques that start to pro-
ject into the lumen experience high shear stress at their 
most stenotic regions, which promotes plaque destabili-
zation (Fukumoto et al. 2008). The vascular response to 
the altered shear stress is also a determinant of plaque 
stability and the progression of atherosclerosis (Koski-
nas et al. 2010). Expanded arterial remodeling occurs in 
exposed lesions with high shear stress, leading to physi-
ological and adaptive arterial enlargement to preserve 
the lumen and, subsequently, to restore shear stress to a 
more physiological level (Dhawan et al. 2010). In the cur-
rent study, we focused the vascular maladaptive response 
to increased shear stress as a coronary risk marker 
because the dysfunctional response finely corresponded 
to the presence of IHD. By contrast, Gori et  al. (2008) 
demonstrated that the vascular maladaptive response 
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Fig. 3 Comparisons of the change in arterial pulse amplitude and the value of flow-mediated dilation (FMD) between subjects with and without 
each coronary risks (a) or high age (b) or IHD (c)
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to low shear stress also corresponds to the existence of 
IHD. However investigation is required to elucidate the 
more concise relationship between the vascular response 
to altered shear stress and the risk of atherosclerosis 
progression.
In the current study, we observed brachial arterial 
behavior. Endothelial function investigated at the bra-
chial artery has been reported to be correlated with that 
in the coronary artery (Teragawa et al. 2005). Therefore, a 
dysfunctional brachial artery is thought to correspond to 
a decreased compensative potency of the coronary artery, 
which is related to coronary events.
In conclusion, enhancement of the arterial pulse ampli-
tude during FMD is significantly suppressed by the pres-
ence of IHD, and the response is independent of the 
FMD. Further prospective studies to investigate the char-
acteristics of this measurement modality in more detail 
are warranted.
Limitations
The primary limitations of this study are the small sample 
size and the retrospective nature of the data collection. 
Therefore, the results should be confirmed in larger stud-
ies in more robust way. The administration of hemody-
namically-effective medications was not well coordinated 
among the subjects and shear stress was not adjusted 
between each subject. In addition, there were several 
points (in particular, gender ratio and the ratio of hyper-
tension) that were significantly different between sub-
jects with and without IHD. However, gender difference 
and the presence of hypertension did not affect the value 
of the change in arterial pulse amplitude in the current 
study (Additional file 1: Figures S1, S2). The association 
between vascular injury and the change in the arterial 
pulse amplitude was demonstrated clearly and robustly. 
Furthermore, in the FMD protocol performed in the cur-
rent study, the increase of shear stress is set appropri-
ately for the evaluation of a nitric-oxide-derived response 
(Mullen et al. 2001). Therefore, differences in shear stress 
induction may be more potent for the enhanced arterial 
pulse amplitude during changes in shear stress (Pyke and 
Tschakovsky 2005).
The present study remains a preliminary report. We 
cannot confirm the basic characteristics of this measure-
ment modality, including the intraclass correlation ratio 
of the measurements. Prospective studies are warranted 
for further investigation.
Additional file
Additional file 1: Figures S1 and S2. The difference in the change in 
arterial pulse amplitude between male and female or with and without 
hypertension.
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